Fresenius Medical Care Financial Statements
NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD
Market open · Delayed 15 min · as of Oct 9, 1:34 PM ET
Fresenius Medical Care revenue and earnings
In fiscal 2013, Fresenius Medical Care generated $4.97 billion in revenue, down 64.0% from fiscal 2012, the first decline in the 7 years shown. Net income was $1.11 billion (-6.5% year over year), for a net margin of 22.3% versus a median of 8.3% in the prior 5 years. Gross margin was 95.3% (up from 33.3%) and operating margin 45.4%.
Diluted earnings per share came in at $3.65, down from $3.87. Over the last 5 fiscal years, FMS's revenue has grown at a -14.1% compound annual rate (a contraction).
Summary generated from market data by MetaCap's automated system. Methodology
Fresenius Medical Care income statement (annual)
| Fiscal year (USD) | FY 20132013-12-31 | FY 20122012-12-31 | FY 20112011-12-31 | FY 20102010-12-31 | FY 20092009-12-31 | FY 20082008-12-31 | FY 20072007-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.97B | 13.80B | 12.57B | 11.84B | 11.25B | 10.61B | 9.72B |
| Revenue growth (YoY) | -63.98% | +9.78% | +6.13% | +5.31% | +5.99% | +9.18% | — |
| Cost of Revenue | 9.87B | 9.20B | 8.42B | 8.01B | 7.42B | 6.98B | 6.36B |
| Gross Profit | 4.74B | 4.60B | 4.15B | 3.84B | 3.83B | 3.63B | 3.36B |
| Operating Expenses | 2.48B | 2.38B | 2.08B | 1.91B | 2.08B | 1.96B | 1.78B |
| Research & Development | 125.81M | 111.63M | 110.83M | 96.53M | 93.81M | 80.24M | 66.52M |
| Selling, General & Admin | 2.38B | 2.22B | 2.00B | 1.82B | 1.99B | 1.88B | 1.71B |
| Operating Income | 2.26B | 2.22B | 2.07B | 1.92B | 1.76B | 1.67B | 1.58B |
| Interest Expense | 447.50M | 470.53M | 356.36M | 305.47M | 321.36M | 361.55M | 399.63M |
| Other Income (Expense) | — | — | 0 | 0 | 0 | — | — |
| Pretax Income | 1.85B | 1.93B | 1.78B | 1.64B | 1.46B | 1.34B | 1.21B |
| Income Tax | 592.01M | 605.14M | 601.10M | 578.35M | 490.41M | 475.70M | 453.76M |
| Net Income | 1.11B | 1.19B | 1.07B | 978.52M | 891.14M | 817.61M | 717.13M |
| Net Income growth (YoY) | -6.48% | +10.80% | +9.47% | +9.81% | +8.99% | +14.01% | — |
| EPS (Basic) | 3.65 | 3.89 | 3.54 | 3.25 | 2.99 | 2.75 | 2.43 |
| EPS (Diluted) | 3.65 | 3.87 | 3.51 | 3.24 | 2.99 | 2.74 | 2.42 |
| Shares Outstanding (Basic) | 301.88M | 301.14M | 299.01M | 296.81M | 294.42M | 293.23M | — |
| Shares Outstanding (Diluted) | 302.55M | 302.90M | 300.81M | 298.12M | 294.42M | 294.01M | — |
| EBITDA | 2.90B | 2.82B | 2.63B | 2.43B | 2.21B | 2.09B | 1.94B |
| Gross Margin | 95.33% | 33.34% | 33.03% | 32.38% | 34.07% | 34.19% | 34.52% |
| Operating Margin | 45.39% | 16.08% | 16.51% | 16.24% | 15.61% | 15.76% | 16.26% |
| Net Margin | 22.33% | 8.60% | 8.52% | 8.26% | 7.92% | 7.70% | 7.38% |
This table shows 7 annual periods of Fresenius Medical Care's income statement, from FY 2013 back to FY 2007, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow FMS's reporting calendar. What is a income statement?